Latest Brain tumor Stories
HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc.
G-202 Data in HCC Patients (Phase I and Phase II) Highly Suggestive of Positive Clinical Activity SAN ANTONIO, June 24, 2014 /PRNewswire/ -- GenSpera, Inc.
A blue-ribbon team of national experts on brain cancer says that professional pessimism and out-of-date "myths," rather than current science, are guiding -- and compromising -- the care of patients with cancers that spread to the brain.
Using CyberKnife and chemotherapy, doctors treat primary and metastatic tumors FENTON, Mo., June 24, 2014 /PRNewswire/ -- When St.
WESTERVILLE, Ohio, June 23, 2014 /PRNewswire/ -- Columbus CyberKnife, a service of Mount Carmel St.
SAN ANTONIO, June 23, 2014 /PRNewswire/ -- GenSpera, Inc.
Dr. Leroy Hood, Institute for Systems Biology President, Accepts CEF’s Annual Inspirational Award on Dr.
Company Refutes Latest Feuerstein False Headline and Attacks BETHESDA, Md., June 20, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company
New research report “Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany” elaborated
- A trick or prank.